The U.S. Food and Drug Administration on Monday approved updated mRNA COVID vaccines from Moderna Inc. and Pfizer Inc. People five years of age and older are...
The U.S. Food and Drug Administration on Monday approved updated mRNA COVID vaccines from Moderna Inc.
and Pfizer Inc. PFE, -1.07%. People five years of age and older are eligible for a single dose of an updated mRNA vaccine if at least two months have passed since their last COVID shot, while previously vaccinated children six months through four years of age are eligible for one or two doses of an updated shot, depending on the previous vaccine they received, according to the FDA.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseThe Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
Read more »
4 Huge Analyst Calls: Block Slashed on 'Lack of Catalysts'; Chewy Bumped to BuyStocks Analysis by Investing.com (Garrett Cook) covering: Block Inc, Chewy Inc, Cloudflare Inc, Surf Air Mobility Inc. Read Investing.com (Garrett Cook)'s latest article on Investing.com
Read more »
Pfizer and Moderna Covid Vaccines Approved by FDA. When They Could Become Available.This year’s rollout marks a definitive transition to a commercial market for the shots., which had previously been purchased by the U.S. government.
Read more »
GE HealthCare Technologies Inc Stock Price Today | NASDAQ GEHC Live TickerView today's GE HealthCare Technologies Inc stock price and latest GEHC news and analysis. Create real-time notifications to follow any changes in the live stock price.
Read more »
US approves updated COVID vaccines to rev up protection this fallU.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter
Read more »
Immatics shares rise on Moderna cancer collaborationImmatics NV shares gained more than 6% premarket on Monday after the company announced a collaboration with Moderna Inc. to research and develop new cancer...
Read more »